Irva Injection

About Irva 1 gm/vial Injection

Irva is a hospital antibiotic injection containing cefoxitin, a second-generation cephalosporin. It is given by a healthcare professional to treat certain serious bacterial infections, and the doctor decides the dose and course.

There are 4 brands of Cefoxitin listed in Bangladesh.

What is Irva 1 gm/vial Injection?

Irva 1 gm/vial is an injection form of cefoxitin, a second-generation cephalosporin antibiotic. It works by blocking the building of the bacterial cell wall, which stops bacteria from surviving and multiplying. Because it is an injection, it is given by a doctor or nurse, usually in a hospital or clinic setting. Cefoxitin is used for certain serious infections caused by bacteria that are susceptible to it. Irva is made by Square Pharmaceuticals PLC. Only a qualified healthcare professional should decide whether this medicine is suitable and how it should be given.

Uses of Irva

Irva is used for certain serious bacterial infections, including some lower respiratory tract infections such as pneumonia and lung abscess, when the infection is caused by bacteria that respond to cefoxitin. It belongs to the second-generation cephalosporin group of antibiotics. It is not for viral infections such as colds or flu. The doctor decides whether it is the right antibiotic for a particular infection.

How to use Irva

Irva is given by a doctor or nurse as an injection, usually into a vein. You should not try to give it yourself. The doctor decides the dose, how often it is given and how long the course lasts, based on the infection and the person's condition. Follow the healthcare team's instructions and tell them about any other medicines being taken, including those bought without a prescription.

Side effects of Irva

Some people may have side effects with cefoxitin. These can include allergic skin reactions such as rash, itching or hives, and fever or swelling. Changes in kidney or liver test results and blood count changes have been reported, as well as digestive effects such as nausea, vomiting and diarrhoea. Inflammation of the vein at the injection site can occur. Anyone with a severe reaction should get medical help. Ask the doctor or pharmacist about any side effect that worries you.

Safety and precautions

Irva should not be used by anyone who is allergic to cefoxitin or to other cephalosporin antibiotics. Tell the doctor before treatment if you have had an allergic reaction to penicillin, have a bowel or stomach condition, especially colitis, have a seizure disorder, or have kidney problems. Pregnancy and breastfeeding should also be discussed with the doctor. The doctor decides whether this medicine is appropriate. Ask the doctor or pharmacist first about any concern, including interactions with other medicines.

Frequently asked questions

What does the generic name cefoxitin mean?

Cefoxitin is the generic name of the active substance in Irva. It belongs to the cephalosporin family of antibiotics, specifically the second-generation cephalosporins. The brand name Irva is the product name used by its manufacturer, while cefoxitin describes the medicine itself.

What is Irva used for and what kind of medicine is it?

Irva is an antibiotic injection in the second-generation cephalosporin group. It is used for certain serious bacterial infections caused by bacteria that respond to cefoxitin, including some lower respiratory tract infections. It does not treat viral infections. The doctor decides if it is suitable for a particular infection.

Who should avoid Irva or ask the doctor first?

Anyone allergic to cefoxitin or other cephalosporins should avoid it. Tell the doctor first if you have had a penicillin allergy, a bowel condition such as colitis, a seizure disorder or kidney problems, or if you are pregnant or breastfeeding. The doctor will decide whether it is appropriate.

Can Irva be given at home?

Irva is an injection and is normally given by a doctor or nurse in a hospital or clinic. Do not attempt to give it yourself. Ask the healthcare team how it will be given and what to do if a problem appears after the injection.

Indications

Cefoxitin is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below.

Lower respiratory tract infections, including pneumonia and lung abscess, caused by Streptococcus ... Read moreCefoxitin is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below.

Lower respiratory tract infections, including pneumonia and lung abscess, caused by Streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., Enterococcus faecalis), Staphylococcus aureus(including penicillinaseproducing strains), Escherichia coli, Klebsiella species, Haemophilus influenzae, and Bacteroides species.

Urinary tract infections caused by Escherichia coli, Klebsiella species, Proteus mirabilis, Morganella morganii, Proteus vulgarisand Providencia species (including P. rettgeri).

Intra-abdominal infections, including peritonitis and intra-abdominal abscess, caused by Escherichia coli, Klebsiella species, Bacteroides species including Bacteroides fragilis, and Clostridium species.

Gynecological infections, including endometritis, pelvic cellulitis, and pelvic inflammatory disease caused by Escherichia coli, Neisseria gonorrhoeae (including penicillinase-producing strains), Bacteroides species including B. fragilis, Clostridium species, Peptococcus niger, Peptostreptococcus species, and Streptococcus agalactiae. Cefoxitin, like cephalosporins, has no activity against Chlamydia trachomatis. Therefore, when Cefoxitin is used in the treatment of patients with pelvic inflammatory disease and C. trachomatis is one of the suspected pathogens, appropriate anti-chlamydial coverage should be added.

Septicemia caused by Streptococcus pneumoniae, Staphylococcus aureus (including penicillinase-producing strains), Escherichia coli, Klebsiella species, and Bacteroides species including B. fragilis.

Bone and joint infections caused by Staphylococcus aureus (including Penicillinaseproducing strains).

Skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains), Staphylococcus epidermidis, Streptococcus pyogenes and other streptococci (excluding enterococci e.g., Enterococcus faecalis), Escherichia coli, Proteus mirabilis, Klebsiella species, Bacteroides species includingB. fragilis, Clostridium species, Peptococcus niger, and Peptostreptococcus species.

Pharmacology

Cefoxitin inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins (PBPs) which in turn inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

Dosage & Administration

Intravenous:

Abdominal infections, Bone and joint infections, Gynaecological infections, Respiratory tract infections, Skin and skin structure infections, Urinary tract infections:
  • Adult: 1-2 g 6-8 hrly, up to 12 g daily given in 4-6 divided doses in severe infections. Doses are given by slow inj over 3-5 min or, by intermittent or continuous infusion.
  • Child: ≥3 mth 80-160 mg/kg daily in 4-6 equally divided doses. Max: 12 g daily.
Prophylaxis of surgical infections:
  • Adult: 2 g 30-60 min prior to surgery, then 6 hrly for not more than 24 hr. For caesarean section: 2 g as a single dose as soon as the umbilical cord is clamped; a further 2 g dose 4 hr and 8 hr after the initial dose may be given if necessary.
  • Child: ≥3 mth 30-40 mg/kg 30-60 min prior to surgery, then 6 hrly for not more than 24 hr.

Interaction

Reduces renal clearance with probenecid. Concurrent use of nephrotoxic agents (e.g. aminoglycosides, colistin, polymyxin B, vancomycin) may increase the risk of nephrotoxicity.

Contraindications

Hypersensitivity to cefoxitin and other cephalosporins.

Side Effects

Hypersensitivity reactions (e.g. maculopapular or erythematous rash, exfoliative dermatitis, pruritus, urticaria, eosinophilia, fever, angioedema); elevated serum creatinine and/or BUN concentrations, anaemia; transient increase in serum AST (SGOT), ALT (SGPT), LDH and alkaline phosphatase levels; jaundice; thrombophlebitis. Rarely, oliguria, renal toxicity, neutropenia, transient leucopenia, granulocytopenia, thrombocytopenia, bone marrow depression; GI effects (e.g. nausea, vomiting, diarrhoea).

Pregnancy & Lactation

Pregnancy Category B. Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).

Precautions & Warnings

Patient with history of penicillin allergy, GI disease (particularly colitis) and seizure disorder. Renal impairment. Pregnancy and lactation.

Storage Conditions

Store between 2-25° C.

Alternative brands of Cefoxitin

Other brands with the same generic name, cheapest first.

Aboxitin Injection

1 gm/vial

Cefoxitin

Incepta Pharmaceuticals Ltd.

Price not listed

Foxitane Injection

1 gm/vial

Cefoxitin

Advanced Chemical Industries PLC

Price not listed

Foxitane Injection

2 gm/vial

Cefoxitin

Advanced Chemical Industries PLC

Price not listed

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.